- Category
- Medium (2023-24)
- Udyam number
- UDYAM-HP-11-0000845

About Shiva Biogenetic Pharmaceuticals Private Limited
Data last updated:
Shiva Biogenetic Pharmaceuticals Private Limited is a private limited company based in Solan, Himachal Pradesh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 16 September 2005 and has been in existence for over 21 years.
The company is registered with the Registrar of Companies (ROC), Himachal Pradesh, under CIN U24032HP2005PTC010765. Its GSTIN is 02AAJCS9364F1Z8 (Himachal Pradesh). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹3.32 Cr and a paid-up capital of ₹2.25 Cr. It is led by directors including Kapil Bhardwaj and Kanhaiya Bhardwaj.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Village Manpura Tehsil Baddi, Solan Himachal Pradesh, Himachal Pradesh, India – 174101.
As per the financials filed for FY 2025, the company reported a revenue of ₹107.81 Cr, a decline of 23% compared to the previous year. For the same year it recorded a net profit of ₹1.39 Cr (net margin 1.3%) and EBITDA of ₹3.9 Cr (EBITDA margin 3.6%). Revenue has declined at a compounded annual rate (CAGR) of 12% over three years and 5% over five years.
The company has about 149 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Shiva Biogenetic. As per MCA filings, the company has open charges of ₹21 Cr and satisfied charges of ₹18.46 Cr on record. Court records list 12 cases involving the company, including 4 filed by the company and 8 filed against it; 6 cases are pending. The company has 9 deals on record (6 secondary share transfers, 3 funding rounds), with disclosed funding of ₹2.24 Cr; the latest was in June 2023. Its 3 peer companies in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 1 larger and 2 smaller; the largest is Chemtech Intermediates Limited with revenue of ₹109 Cr. The company has 4 MSME Form 1 returns on record between 2019 and 2022, listing 388 overdue payments to 98 micro and small suppliers.
Shiva Biogenetic Pharmaceuticals Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-HP-11-0000845). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website shivabiogenetic.com.
Company details
CIN history
Shiva Biogenetic Pharmaceuticals has one previous CIN (Corporate Identification Number): U24032DL2005PTC140862. The current CIN is U24032HP2005PTC010765, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24032HP2005PTC010765 | Current |
| U24032DL2005PTC140862 | Previous |
Recognitions & Rankings of Shiva Biogenetic Pharmaceuticals
Contact details
Shiva Biogenetic Pharmaceuticals Private Limited's registered office is in Solan, Himachal Pradesh. Its website is shivabiogenetic.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressVillage Manpura Tehsil Baddi, Solan Himachal Pradesh, Himachal Pradesh, India – 174101
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Shiva Biogenetic Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Shiva Biogenetic Pharmaceuticals operates one associated brand: Shiva Biogenetic. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Pharmaceutical manufacturing and services in India, focusing on third-party operations and quality products. | shivabiogenetic.com |
Business activity
The main business activity of Shiva Biogenetic Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Shiva Biogenetic Pharmaceuticals Private Limited, buy the company report.
Financials of Shiva Biogenetic Pharmaceuticals Private Limited
FY 2024 filings availableShiva Biogenetic Pharmaceuticals Private Limited reported revenue of ₹107.81 Cr (down 23% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 5% over five years, including a 23% fall in the latest year. EBITDA fell 20% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹3.9 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.39 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3.6% | ||||
| Net Profit Margin | 1.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Shiva Biogenetic Pharmaceuticals Private Limited, buy the company report.
Board of directors of Shiva Biogenetic Pharmaceuticals Private Limited
Shiva Biogenetic Pharmaceuticals has 4 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Kapil Bhardwaj Also directs: Shiva Biogenetic Laboratories Private Limited, Jivaay Pharmaceuticals Private Limited, GK Remedies Private Limited and 2 more | Director | 27 Feb 2010 | 16 Years 8 Months | Current |
| Kanhaiya Bhardwaj | Director | 31 Dec 2024 | 1 Years 10 Months | Current |
| Shailendra Kumar Singh Also directs: Shiva Audax Pharmaceuticals Private Limited | Director | 02 Feb 2007 | 19 Years 9 Months | Current |
| Parsan Kumar Singh Also directs: Shiva Biogenetic Laboratories Private Limited | Director | 13 May 2022 | 4 Years 6 Months | Current |
Peer comparison
Shiva Biogenetic Pharmaceuticals Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Chemtech Intermediates Limited | ₹109 Cr (FY 2025) | 33.0% | Vadodara, Gujarat, India | |||
| Shiva Biogenetic Pharmaceuticals Private Limitedthis company | ₹107.81 Cr (FY 2025) | ₹1.39 Cr | 1.3% | -23.0% | 149 | Solan, Himachal Pradesh, India |
| Shivalik Remedies Private Limited | ₹107.31 Cr (FY 2025) | 11.0% | New Delhi, Delhi, India | |||
| Genetek Lifesciences Private Limited | ₹107.01 Cr (FY 2024) | 18.0% | Nagpur, Maharashtra, India |
To see the full peer comparison of Shiva Biogenetic Pharmaceuticals Private Limited, buy the company report.
Auditor
Shiva Biogenetic Pharmaceuticals Private Limited is audited by AARYAA & ASSOCIATES for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| AARYAA & ASSOCIATES | FY 2024 | 015935N |
Shareholding
The shareholding of Shiva Biogenetic Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Shiva Biogenetic Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 26 Nov 2021 | 100525812 | State Bank of India | ₹2 Cr | Open | |
| 03 Jan 2018 | 100162777 | State Bank of India | ₹19 Cr | Open | |
| 23 Jun 2014 | 10510067 | Axis Bank Limited | ₹1.6 Cr | Satisfied | |
| 25 Mar 2010 | 10215226 | Others | ₹4 Cr | Satisfied | |
| 25 Mar 2010 | 10215028 | Axis Bank Limited | ₹2.25 Cr | Satisfied |
To see the full charge records of Shiva Biogenetic Pharmaceuticals Private Limited, buy the company report.
Total charge records: 8 View all charges
Deals & funding
Shiva Biogenetic Pharmaceuticals Private Limited has 9 deals on record (6 secondary share transfers, 3 funding rounds), with disclosed funding of ₹2.24 Cr; the latest was in June 2023.
Deals on record (5 of 9)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Jun 2023 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| May 2023 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Sep 2020 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Mar 2014 | Secondary share transfer | Undisclosed | Buyer: 4 individuals Seller: 2 individuals |
| Jan 2012 | Funding round | ₹19.5 Lakh | Investors: an individual |
To see the full deal history of Shiva Biogenetic Pharmaceuticals Private Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Shiva Biogenetic Pharmaceuticals Private Limited has 12 court cases on record: 4 filed by Shiva Biogenetic Pharmaceuticals, 8 filed against it. 6 cases are pending and 6 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 9 | 8 | 5 |
| High courts | 3 | 0 | 1 |
Cases on record (5 of 12)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Mumbai CMM Courts, Maharashtra | Court case (Summons warrant cases SW) | Filed against the company by State Through Sandip B Datir Drug Inspector | Pending |
| District court, Nagpur, Maharashtra | Civil suit | Filed against the company | Pending |
| High Court, HIMACHAL PRADESH | Interim or miscellaneous application | Filed by the company against State of Hp(Not Applicable) | Pending |
| District court, Ananthapur, Andhra Pradesh | Criminal complaint | Filed against the company by an individual | Pending |
| District court, Pune, Maharashtra | Civil suit | Filed against the company by The State of Maharashtra Through Rohit Shankar Rathod. | Pending |
To see the full case history of Shiva Biogenetic Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Shiva Biogenetic Pharmaceuticals Private Limited has 4 MSME Form 1 returns on record between 2019 and 2022, listing 388 overdue payments to 98 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 98)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| an individual supplier | |||
| Fortcaps Healthcare Limited | |||
| Keshav Hichem Private Limited | |||
| Sain Packaging Private Limited | |||
| Grand Tech Solution |
To see the full MSME payment records of Shiva Biogenetic Pharmaceuticals Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Shiva Biogenetic Pharmaceuticals Private Limited has a workforce of 149 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2026-27 | 149 |
| FY 2025-26 | |
| FY 2024-25 | |
| FY 2023-24 | |
| FY 2022-23 | |
| FY 2021-22 | |
| FY 2020-21 | |
| FY 2019-20 | |
| FY 2018-19 | |
| FY 2017-18 | |
| FY 2016-17 |
To see the full employee and EPFO history of Shiva Biogenetic Pharmaceuticals Private Limited, buy the company report.
GST
Shiva Biogenetic Pharmaceuticals has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 02AAJCS9364F1Z8 | Himachal Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Shiva Biogenetic Pharmaceuticals Private Limited, buy the company report.
Recent activity
Shiva Biogenetic Pharmaceuticals Private Limited has 9 board changes on record since 2005: 5 appointments and 4 cessations. The latest: Kanhaiya Bhardwaj was appointed as Director on 31 Dec 2024.
17 earlier events are in the company report.
Frequently asked questions
Shiva Biogenetic Pharmaceuticals is an active private limited company based in Solan, Himachal Pradesh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 16 September 2005 (21+ years old) and is registered under CIN U24032HP2005PTC010765.
Shiva Biogenetic Pharmaceuticals has 4 current directors:
- Kapil Bhardwaj - Director
- Kanhaiya Bhardwaj - Director
- Shailendra Kumar Singh - Director
- Parsan Kumar Singh - Director
The latest financial statements of Shiva Biogenetic Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Shiva Biogenetic Pharmaceuticals is 02AAJCS9364F1Z8, registered in Himachal Pradesh. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Shiva Biogenetic Pharmaceuticals is U24032HP2005PTC010765. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Shiva Biogenetic Pharmaceuticals has 12 court cases on record: 4 filed by the company and 8 filed against it. 6 are pending. Most are in the district courts.
Shiva Biogenetic Pharmaceuticals was incorporated on 16 September 2005, making it 21+ years old. It is registered with the Registrar of Companies, Himachal Pradesh.
Shiva Biogenetic Pharmaceuticals has 9 deals on record (6 secondary share transfers, 3 funding rounds), with disclosed funding of ₹2.24 Cr; the latest was in June 2023.
The peers of Shiva Biogenetic Pharmaceuticals by revenue are Chemtech Intermediates Limited, Shivalik Remedies Private Limited, Genetek Lifesciences Private Limited, all in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Kanhaiya Bhardwaj was appointed as Director on 31 Dec 2024. Sushila Devi ceased to be Director on 31 Dec 2024. Parsan Kumar Singh was appointed as Director on 13 May 2022. Shiva Biogenetic Pharmaceuticals has 9 board changes on record in total.
Yes, Shiva Biogenetic Pharmaceuticals is registered as a medium enterprise under Udyam registration (number: UDYAM-HP-11-0000845).
Shiva Biogenetic Pharmaceuticals has 4 MSME Form 1 returns on record between 2019 and 2022, listing 388 overdue payments to 98 micro and small suppliers. The latest return was filed on 07 May 2022.

